(Q36606968)

15 August 2017

1 reference

title

Hepatitis C infection in dialysis patients: a link to poor clinical outcome? (English)

1 reference

15 August 2017

0 references

Kamyar Kalantar-Zadeh

1

object named as

Kamyar Kalantar-Zadeh

0 references

author name string

Eric S Daar

2

1 reference

15 August 2017

Viktor E Eysselein

3

1 reference

15 August 2017

Loren G Miller

4

1 reference

15 August 2017

publication date

29 September 2006

1 reference

International Urology and Nephrology

15 August 2017

published in

1 reference

15 August 2017

volume

39

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

247-259

1 reference

HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C.

15 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-006-9075-8

Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients

21 January 2018

1 reference

12 December 2020

Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications

1 reference

12 December 2020

Hepatitis B and C and renal failure

1 reference

12 December 2020

Multicenter Evaluation of the VERSANT HCV RNA Qualitative Assay for Detection of Hepatitis C Virus RNA

1 reference

12 December 2020

Inflammation and nutrition in renal insufficiency

1 reference

12 December 2020

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

1 reference

12 December 2020

Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays

1 reference

12 December 2020

Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population

1 reference

12 December 2020

Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.

1 reference

12 December 2020

Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?

1 reference

12 December 2020

Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989-January 1997).

1 reference

12 December 2020

Obesity paradox as a component of reverse epidemiology in heart failure

1 reference

12 December 2020

Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure.

1 reference

12 December 2020

Liver disease vs systemic inflammation in haemodialysis patients

1 reference

12 December 2020

Hepatitis C virus in blood and dialysate in hemodialysis

1 reference

12 December 2020

Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients

1 reference

12 December 2020

Survival advantages of obesity in dialysis patients

1 reference

12 December 2020

Hepatitis C screening strategies in hemodialysis patients

1 reference

12 December 2020

HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece

1 reference

12 December 2020

Homocysteine in uraemia--a puzzling and conflicting story

1 reference

12 December 2020

Hepatitis C virus infection in a male homosexual cohort: risk factor analysis

1 reference

12 December 2020

Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis

1 reference

12 December 2020

Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays

1 reference

12 December 2020

A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients

1 reference

12 December 2020

Causes and consequences of the reverse epidemiology of body mass index in dialysis patients

1 reference

12 December 2020

Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center

1 reference

12 December 2020

Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction

1 reference

12 December 2020

An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection

1 reference

12 December 2020

World Kidney Day: an idea whose time has come

1 reference

12 December 2020

Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences

1 reference

12 December 2020

Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20.

1 reference

12 December 2020

Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay

1 reference

12 December 2020

Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Recent evidence

1 reference

12 December 2020

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

12 December 2020

1 reference

12 December 2020

Pathophysiology of protein-energy wasting in chronic renal failure

1 reference

12 December 2020

Association of serum albumin and atherosclerosis in chronic hemodialysis patients

1 reference

12 December 2020

Treatment of hepatitis C in potential kidney and heart transplant patients

1 reference

12 December 2020

Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety

1 reference

12 December 2020

Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay

1 reference

12 December 2020

Performance Evaluation of the VERSANT HCV RNA Qualitative Assay by Using Transcription-Mediated Amplification

1 reference

12 December 2020

Hepatitis C virus infection among chronic dialysis patients in the south of France: a collaborative study

1 reference

12 December 2020

Treatment of HCV-related liver diseases after renal transplantation: modern views.

1 reference

12 December 2020

Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.

1 reference

12 December 2020

Comparison of Second- and Third-Generation Enzyme Immunoassays for Detecting Antibodies to Hepatitis C Virus

1 reference

12 December 2020

Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?

1 reference

12 December 2020

High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy

1 reference

12 December 2020

Treatment of acute hepatitis C with interferon alfa-2b

1 reference

12 December 2020

Effect of dialysis dose and membrane flux in maintenance hemodialysis

1 reference

12 December 2020

Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.

1 reference

12 December 2020

Diagnostic discordance for hepatitis C virus infection in hemodialysis patients

1 reference

12 December 2020

Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study

1 reference

12 December 2020

Routine serologic testing for hepatitis C virus infection should be instituted among dialysis patients

1 reference

12 December 2020

The impact of diabetes and obesity on liver histology in patients with hepatitis C.

1 reference

12 December 2020

Contribution of obesity to hepatitis C-related fibrosis progression

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

Kidney insufficiency and nutrient-based modulation of inflammation

1 reference

12 December 2020

Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients

1 reference

12 December 2020

Serum erythropoietin and interleukin-6 levels in hemodialysis patients with hepatitis virus infection

1 reference

12 December 2020

Risk of death among chronic dialysis patients infected with hepatitis C virus

1 reference

12 December 2020

Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial

1 reference

12 December 2020

Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.

1 reference

12 December 2020

Differential induction of serum interleukin-6 and -12 by interferon-α and -β administration in chronic hepatitis C patients

1 reference

12 December 2020

Hepatitis C infection and the patient with end-stage renal disease

1 reference

12 December 2020

Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease

1 reference

12 December 2020

McCollum Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients

1 reference

12 December 2020

Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

1 reference

12 December 2020

Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.

1 reference

12 December 2020

Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy

1 reference

12 December 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

12 December 2020

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis

1 reference

12 December 2020

Patterns of hepatitis C viremia in patients receiving hemodialysis.

1 reference

12 December 2020

Why are dialysis patients malnourished?

1 reference

12 December 2020

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

1 reference

12 December 2020

Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients.

1 reference

12 December 2020

The role of inflammation and infection in coronary artery disease

1 reference

12 December 2020

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

1 reference

12 December 2020

Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response

1 reference

12 December 2020

Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus

1 reference

12 December 2020

Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States

1 reference

12 December 2020

Hepatitis C and renal disease: an update

1 reference

12 December 2020

Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients.

1 reference

12 December 2020

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

1 reference

12 December 2020

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation

1 reference

12 December 2020

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival

1 reference

12 December 2020

Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences

1 reference

12 December 2020

Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia

1 reference

12 December 2020

Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group

1 reference

12 December 2020

Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment

1 reference

12 December 2020

The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study

1 reference

12 December 2020

Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients

1 reference

12 December 2020

Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients

1 reference

12 December 2020

Reverse epidemiology: a spurious hypothesis or a hardcore reality?

1 reference

12 December 2020

Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease

1 reference

12 December 2020

Morbidity and mortality of dialysis

1 reference

12 December 2020

10.1007/S11255-006-9075-8

Identifiers

DOI

1 reference

15 August 2017

1 reference